Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Neto (Porto Alegre (RS), Brazil), B. Spolidoro (Porto Alegre (RS), Brazil), G. Marcolin (Porto Alegre (RS), Brazil), D. Berton (Porto Alegre (RS), Brazil), M. Knorst (Porto Alegre (RS), Brazil). Azithromycin to prevent exacerbations of chronic obstructive pulmonary disease: a study in the real-world setting. 186

Member's Comments

No comment yet.

Related content which might interest you: Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits? Source: ERJ Open Res, 6 (2) 00099-2020; 10.1183/23120541.00099-2020 Year: 2020 An eHealth program to reduce hospitalizations due to acute exacerbation of chronic obstructive pulmonary disease – a real-life study Source: Virtual Congress 2020 – Digital technologies in airway diseases Year: 2020 Proactive integrated care improves quality of life in patients with COPD Source: Eur Respir J 2009; 33: 1031-1038 Year: 2009 Antibiotic effectiveness to prevent new chronic obstructive pulmonary disease (COPD) exacerbations in current medical practice Source: Annual Congress 2009 - Functional insights into COPD Year: 2009 Clinical and economical impact of exacerbations of chronic obstructive pulmonary disease (COPD): A two-year study Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 The effect of long-term macrolides therapy for acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 The impact of using different symptom-based exacerbation algorithms in patients with COPD Source: Eur Respir J 2011; 37: 1260-1268 Year: 2011 Antibiotics in acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Pulmonary rehabilitation and its effect on exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention Year: 2005 Comparison of two physiotherapy treatments in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases Year: 2021 COPD exacerbations in patients with chronic obstructive pulmonary disease in general practice in Ireland Source: Eur Respir J 2004; 24: Suppl. 48, 89s Year: 2004 Acute exacerbations of chronic obstructive pulmonary disease, clinical characteristics and predictors of exacerbations rate Source: Eur Respir J 2006; 28: Suppl. 50, 625s Year: 2006 Roflumilast in severely ill patients with chronic obstructive pulmonary disease with frequent exacerbations: real-life outcomes Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020 Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001 Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed? Source: Eur Respir J 2002; 19: 966-975 Year: 2002 Self-management plans in exacerbations of COPD Source: Annual Congress 2006 - Exacerbation of COPD Year: 2006 Inpatient acute exacerbations of chronic obstructive pulmonary disease clinical pathway: development and initial experience Source: Eur Respir J 2006; 28: Suppl. 50, 625s Year: 2006 Modulation of airway inflammation to prevent exacerbations of COPD Source: Eur Respir Rev 2005; 14: 78-82 Year: 2005 Acute exacerbations of chronic obstructive pulmonary disease (AE-COPD): A qualitative exploratory study of patients’ needs following discharge Source: Virtual Congress 2020 – Pulmonary rehabilitation across the globe Year: 2020